Status:
COMPLETED
Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study
Lead Sponsor:
National Institute of Cardiology, Warsaw, Poland
Collaborating Sponsors:
Solvay Pharmaceuticals
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
30-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Background: Influenza vaccination is recommended in patients (pts) with cardiovascular disease, however there is a shortage of clinical studies proving its protective effect on clinical course of coro...
Detailed Description
A possible relation between influenza and higher mortality from cardiovascular problems was first noticed in early nineteen hundreds, after epidemics in Europe and United States were discovered (1). I...
Eligibility Criteria
Inclusion
- Patients, aged 30-80 years, with CAD confirmed by coronarography with at least 50% stenosis of one large epicardial coronary artery.
Exclusion
- planned cardiovascular surgery within 6 months, congestive heart failure NYHA III/IV, evolving renal failure, neoplastic disease, psycho-organic disorder or any factor impeding follow-up, contraindication to vaccination.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
658 Patients enrolled
Trial Details
Trial ID
NCT00371098
Start Date
October 1 2004
End Date
December 1 2005
Last Update
October 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1st Dept. of Coronary Artery Disease, Institute of Cardiology
Warsaw, Poland, 04-628